Aspirin/dipyridamole cost effective in recurrent stroke

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1221, 2000-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin/dipyridamole beats aspirin in recurrent stroke

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 246, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Antiplatelet Therapy in the Prevention of Recurrent Stroke in the UK: Aspirin, Dipyridamole and Aspirin-Dipyridamole

By Chambers M.

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 577-593

Adis International

Access to resources Recommend Favorite

Dipyridamole plus aspirin cost effective in stroke prevention

Inpharma, Vol. 1, Iss. 1450, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Aspirin plus dipyridamole effective in secondary stroke prevention

Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Aspirin + dipyridamole preferable for stroke prevention

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite